Neonatal glucocorticoid treatment: Long-term effects on the hypothalamus-pituitary-adrenal axis, immune system, and problem behavior in 14-17 year old adolescents

Brain, Behavior, and Immunity

Volumn 45, Issue , 2015, Pages 128-138

  ter Wolbeek, Maike ^a   Kavelaars, Annemieke ^a,b   de Vries, Willem B ^a   Tersteeg Kamperman, Marijke ^a   Veen, Sylvia ^c   Kornelisse, René F ^d   van Weissenbruch, Mirjam ^e   Baerts, Wim ^f   Liem, Kian D ^a,g   van Bel, Frank ^a   Heijnen, Cobi J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ISALA HOSPITAL   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adolescence; Bronchopulmonary dysplasia; Cortisol; Cytokines; Dexamethasone; Glucocorticoid; HPA axis; Hydrocortisone; Neonatal; Problem behavior

Indexed keywords

CORTICOTROPIN; DEXAMETHASONE; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; GLUCOCORTICOID; IL10 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADOLESCENT; ANXIETY; AROUSAL; ARTICLE; BEHAVIOR DISORDER; BIRTH WEIGHT; BLOOD SAMPLING; CHILD BEHAVIOR CHECKLIST; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; DEXAMETHASONE SUPPRESSION TEST; DRUG DOSE REDUCTION; EXERCISE TEST; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IN VITRO STUDY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEGATIVE FEEDBACK; PREMATURITY; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; TRIER SOCIAL STRESS TEST; AGGRESSION; BRONCHOPULMONARY DYSPLASIA; CASE CONTROL STUDY; CHEMISTRY; DEPRESSION; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; IMMUNOLOGY; LONGITUDINAL STUDY; MENTAL STRESS; METABOLISM; NEWBORN; PATHOPHYSIOLOGY; PSYCHOLOGY; SALIVA; SEX DIFFERENCE;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; AGGRESSION; ANXIETY; BRONCHOPULMONARY DYSPLASIA; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOKINES; DEPRESSION; DEXAMETHASONE; FEMALE; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNE SYSTEM; INFANT, NEWBORN; INFANT, PREMATURE; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; PITUITARY-ADRENAL SYSTEM; SALIVA; SEX FACTORS; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924041963     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.10.017     Document Type: Article

References (66)

1. Achenbach T.M., Rescorla L. The Manual for the ASEBA School-Age Forms & Profiles 2001, University of Vermont, Research Center for Children, Youth, and Families, Burlington.
2. Achenbach T.M. Manual for the Child Behavioral Checklist/4-18 and 1991 Profile 1992, Department of Psychiatry, University of Vermont, Burlington, VT.
3. Alexander N., Rosenlöcher F., Stalder T., Linke J., Distler W., Morgner J., Kirschbaum C. Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children. J. Clin. Endocrinol. Metab. 2012, 97(10):3538-3544.
4. Bakker J.M., Kavelaars A., Kamphuis P.J., Cobelens P.M., van Vugt H.H., van Bel F., Heijnen C.J. Neonatal dexamethasone treatment increases susceptibility to experimental autoimmune disease in adult rats. J. Immunol. 2000, 165(10):5932-5937.
5. Barrington K.J. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr. 2001, 1:1.
6. Buske-Kirschbaum A., Jobst S., Wustmans A., Kirschbaum C., Rauh W., Hellhammer D. Attenuated free cortisol response to psychosocial stress in children with atopic dermatitis. Psychosom. Med. 1997, 59(4):419-426.
7. Coddington R.D. The significance of life events as etiologic factors in the diseases of children. II. A study of a normal population. J. Psychosom. Res. 1972, 16:205-213.
8. Comparison chart: Adrenal Cortical Steroids Drug Facts and Comparisons 1997, 122-128. Facts and Comparisons, Inc., St. Louis. 5th ed.
9. De Jong S.E., Groenendaal F., van Bel F., Rademaker K.J. Pulmonary effects of neonatal hydrocortisone treatment in ventilator-dependent preterm infants. Int. J. Pediatr. 2011, 783-893.
10. De Kloet E.R., Vreugdenhil E., Oitzl M.S., Joëls M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 1998, 19:269-301.
11. De Vries W.B., Karemaker R., Mooy N.F., Strengers J.L., Kemperman H., Baerts W., Veen S., Visser G.H., Heijnen C.J., van Bel F. Cardiovascular follow-up at school age after perinatal glucocorticoid exposure in prematurely born children: perinatal glucocorticoid therapy and cardiovascular follow-up. Arch. Pediatr. Adolesc. Med. 2008, 162:738-744.
12. Doyle L.W., Ehrenkranz R.A., Halliday H.L. Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology 2010, 98:111-117.
13. Foley P., Kirschbaum C. Human hypothalamus-pituitary-adrenal axis responses to acute psychosocial stress in laboratory settings. Neurosci. Biobehav. Rev. 2010, 35(1):91-96.
14. Giedion A., Haefliger H., Dangel P. Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure (PEP). Pediatr. Radiol. 1973, 1:145-152.
15. Gordijn M.S., van Litsenburg R.R., Gemke R.J., Bierings M.B., Hoogerbrugge P.M., van de Ven P.M., Heijnen C.J., Kaspers G.J. Hypothalamic-pituitary-adrenal axis function in survivors of childhood acute lymphoblastic leukemia and healthy controls. Psychoneuroendocrinology 2012, 37(9):1448-1456.
16. Gunnar M.R., Wewerka S., Frenn K., Long J.D., Griggs C. Developmental changes in hypothalamus-pituitary-adrenal activity over the transition to adolescence: normative changes and associations with puberty. Dev. Psychopathol. 2009, 21(1):69-85.
17. Halliday H.L. The effect of postnatal steroids on growth and development. J. Perinat. Med. 2001, 29(4):281-285.
18. Handa R.J., Burgess L.H., Kerr J.E., O'Keefe J.A. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm. Behav. 1994, 28(4):464-476.
19. Hanrahan K., McCarthy A.M., Kleiber C., Lutgendorf S., Tsalikian E. Strategies for salivary cortisol collection and analysis in research with children. Appl. Nurs. Res. 2006, 19(2):95-101.
20. Jones R.A., Collaborative Dexamethasone Trial Follow-up Group Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes. Pediatrics 2005, 16:370-378.
21. Kaempf J.W., Campbell B., Sklar R.S., Arduza C., Gallegos R., Zabari M., Brown A., McDonald J.V. Implementing potentially better practices to improve neonatal outcomes after reducing postnatal dexamethasone use in infants born between 501 and 1250 grams. Pediatrics 2003, 111:e534-e541.
22. Kamphuis P.J., Bakker J.M., Broekhoven M.H., Kunne C., Croiset G., Lentjes E.G., Tilders F.J., van Bel F., Wiegant V.M. Enhanced glucocorticoid feedback inhibition of hypothalamo-pituitary-adrenal responses to stress in adult rats neonatally treated with dexamethasone. Neuroendocrinology 2002, 76:158-169.
23. Kamphuis P.J., Croiset G., Bakker J.M., Van Bel F., Van Ree J.M., Wiegant V.M. Neonatal dexamethasone treatment affects social behaviour of rats in later life. Neuropharmacology 2004, 47(3):461-474.
24. Kamphuis P.J., de Vries W.B., Bakker J.M., Kavelaars A., van Dijk J.E., Schipper M.E., van Oosterhout M.F., Croiset G., Heijnen C.J., van Bel F., Wiegant V.M. Reduced life expectancy in rats after neonatal dexamethasone treatment. Pediatr. Res. 2007, 61(1):72-76.
25. Kapoor A., Petropoulos S., Matthews S.G. Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Res. Rev. 2008, 57(2):586-595.
26. Karemaker R., Heijnen C.J., Veen S., Baerts W., Samsom J., Visser G.H., Kavelaars A., van Doornen L.J., van Bel F. Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone. Pediatr. Res. 2006, 60:745-750.
27. Karemaker R., Kavelaars A., ter Wolbeek M., Tersteeg-Kamperman M., Baerts W., Veen S., Samsom J.F., Visser G.H., van Bel F., Heijnen C.J. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age. Pediatrics 2008, 121:e870-e878.
28. Karemaker R., Karemaker J.M., Kavelaars A., Tersteeg-Kamperman M., Baerts W., Veen S., Samsom J.F., van Bel F., Heijnen C.J. Effects of neonatal dexamethasone treatment on the cardiovascular stress response of children at school age. Pediatrics 2008, 122:978-987.
29. Kiechl-Kohlendorfer U., Ralser E., Pupp Peglow U., Reiter G., Trawöger R. Adverse neurodevelopmental outcome in preterm infants: risk factor profiles for different gestational ages. Acta Paediatr. 2009, 98(5):792-796.
30. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28(1-2):76-81.
31. Kudielka B.M., Hellhammer D.H., Kirschbaum C. Ten years of research with the Trier Social Stress Test-revisited. Social Neuroscience: Integrating Biological and Psychological Explanations of Social Behavior 2007, The Guilford Press, New York. E. Harmon-Jones, P. Winkielman (Eds.).
32. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972, 50(4):515-525.
33. Luo Z.C., Wilkins R., Kramer M.S. Effect of neighbourhood income and maternal education on birth outcomes: a population-based study. CMAJ 2006, 174(10):1415-1420. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System.
34. McArthur S., Siddique Z.L., Christian H.C., Capone G., Theogaraj E., John C.D., Smith S.F., Morris J.F., Buckingham J.C., Gillies G.E. Perinatal glucocorticoid treatment disrupts the hypothalamo-lactotroph axis in adult female, but not male, rats. Endocrinology 2006, 147(4):1904-1915.
35. Meijman T.F.T., Thunnissen M.J., de Vries-Griever A.G. The after-effects of a prolonged period of day-sleep on subjective sleep quality. Work Stress 1990, 4:65-70.
36. Mwansa-Kambafwile J., Cousens S., Hansen T., Lawn J.E. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int. J. Epidemiol. 2010, 39(Suppl. 1):122-133.
37. Ng P.C. The fetal and neonatal hypothalamic-pituitary-adrenal axis. Arch. Dis. Child. Fetal Neonatal Ed. 2000, 82(3):F250-F254.
38. Onland W., Offringa M., De Jaegere A.P., van Kaam A.H. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials. Pediatrics 2009, 123:367-377.
39. O'Shea T.M., Washburn L.K., Nixon P.A., Goldstein D.J. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age. Pediatrics 2007, 120:594-602.
40. Papile L.A., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J. Pediatr. 1978, 92:529-534.
41. Pruessner J.C., Gaab J., Hellhammer D.H., Lintz D., Schommer N., Kirschbaum C. Increasing correlations between personality traits and cortisol stress responses obtained by data aggregation. Psychoneuroendocrinol. 1997, 22:615-625.
42. Pruessner J.C., Kirschbaum C., Meinlschmid G., Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28(7):916-931.
43. Rademaker K.J., de Vries W.B. Long-term effects of neonatal hydrocortisone treatment for chronic lung disease on the developing brain and heart. Semin. Fetal Neonatal Med. 2009, 14(3):171-177.
44. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst. Rev. 2006, 19(3):CD004454.
45. Shinwell E.S., Lerner-Geva L., Lusky A., Reichman B. Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants. Arch. Dis. Child. Fetal Neonatal Ed. 2007, 92:F30-F33.
46. Shinwell E.S. Current dilemmas in postnatal steroid therapy for chronic lung disease in preterm infants. Biol. Neonate 2003, 84(1):96-100.
47. Stålnacke J., Diaz Heijtz R., Norberg H., Norman M., Smedler A.C., Forssberg H. Cognitive outcome in adolescents and young adults after repeat courses of antenatal corticosteroids. J. Pediatr. 2013, 163(2):441-446.
48. Stroud L.R., Papandonatos G.D., Williamson D.E., Dahl R.E. Sex differences in the effects of pubertal development on responses to a corticotropin-releasing hormone challenge: the Pittsburgh psychobiologic studies. Ann. N.Y. Acad. Sci. 2004, 1021:348-351.
49. Stroud L.R., Foster E., Papandonatos G.D., Handwerger K., Granger D.A., Kivlighan K.T., Niaura R. Stress response and the adolescent transition: performance versus peer rejection stressors. Dev. Psychopathol. 2009, 21(1):47-68.
50. Stroud L.R., Papandonatos G.D., Williamson D.E., Dahl R.E. Sex differences in cortisol response to corticotropin releasing hormone challenge over puberty: Pittsburgh pediatric neurobehavioral studies. Psychoneuroendocrinology 2011, 36(8):1226-1238.
51. Tanner J.M. Growth at Adolescence. With a General Consideration of the Effects of Hereditary and Environmental Factors upon Growth and Maturation from Birth to Maturity 1962, Blackwell Scientific, Oxford. 2nd ed.
52. Ter Wolbeek M., van Doornen L.J., Coffeng L.E., Kavelaars A., Heijnen C.J. Cortisol and severe fatigue: a longitudinal study in adolescent girls. Psychoneuroendocrinology 2007, 32(2):171-182.
53. Ter Wolbeek M., van Doornen L.J., Kavelaars A., van de Putte E.M., Schedlowski M., Heijnen C.J. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents. Brain Behav. Immun. 2007, 21(8):1063-1074.
54. Ter Wolbeek M., de Sonneville L.M., de Vries W.B., Kavelaars A., Veen S., Kornelisse R.F., van Weissenbruch M., Baerts W., Liem K.D., van Bel F., Heijnen C.J. Early life intervention with glucocorticoids has negative effects on motor development and neuropsychological function in 14-17 year-old adolescents. Psychoneuroendocrinology 2013, 38(7):975-986.
55. Uhart M., Chong R.Y., Oswald L., Lin P.I., Wand G.S. Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivity. Psychoneuroendocrinology 2006, 31(5):642-652.
56. Van der Heide-Jalving M., Kamphuis P.J., van der Laan M.J., Bakker J.M., Wiegant V.M., Heijnen C.J., Veen S., van Bel F. Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?. Acta Paediatr. 2003, 92:827-835.
57. Vázquez D.M., Neal C.R., Patel P.D., Kaciroti N., López J.F. Regulation of corticoid and serotonin receptor brain system following early life exposure of glucocorticoids: long term implications for the neurobiology of mood. Psychoneuroendocrinology 2012, 37(3):421-437.
58. Veerman J.W., Ten Brink L.T., Van der Horst H., Koedoot P. Vragenlijst Meegemaakte Gebeurtenissen: Revised Manual (VMG) 1993, Paedological Institute, Amsterdam.
59. Verhulst F.C., van der Ende J., Koot H.M. Handleiding voor de Youth Self Report (YSR) 1997, Afdeling Kinder- en Jeugdpsychiatrie, Sophia Kinderziekenhuis/Academisch Ziekenhuis Rotterdam/Erasmus Universiteit Rotterdam, Rotterdam.
60. Walsh M.C., Yao Q., Horbar J.D., Carpenter J.H., Lee S.K., Ohlsson A. Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks. Pediatrics 2006, 118:e1328-e1335.
61. Watterberg K.L. Policy statement-postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics 2010, 126(4):800-808. American Academy of Pediatrics, Committee on Fetus and NewbornCommittee on Fetus and Newborn.
62. Weaver S.A., Aherne F.X., Meaney M.J., Schaefer A.L., Dixon W.T. Neonatal handling permanently alters hypothalamic-pituitary-adrenal axis function, behaviour, and body weight in boars. J. Endocrinol. 2000, 164(3):349-359.
63. Wong D., Abdel-Latif M., Kent A. Antenatal steroid exposure and outcomes of very premature infants: a regional cohort study. Arch. Dis. Child. Fetal Neonatal Ed. 2014, 99(1):F12-F20.
64. Yates H.L., Newell S.J. Minidex: very low dose dexamethasone (0.05 mg/kg/day) in chronic lung disease. Arch. Dis. Child. Fetal Neonatal Ed. 2011, 96(3):190-194.
65. Yeh T.F., Lin Y.J., Lin H.C., Huang C.C., Hsieh W.S., Lin C.H., Tsai C.H. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N. Engl. J. Med. 2004, 25:1304-1313.
66. Zhang T.Y., Meaney M.J. Epigenetics and the environmental regulation of the genome and its function. Annu. Rev. Psychol. 2010, 61:439-466.